Mergers & Acquisitions - Mergers & Acquisitions, Generics

Filter

Popular Filters

76 to 100 of 175 results

Endo Health expends $225 million on generic acquisition

29-08-2013

USA-based specialty health care company Endo Health Solutions (Nasdaq: ENDP) says that that its Qualitest…

Boca PharmacalEndo Health SolutionsGenericsMergers & AcquisitionsPharmaceutical

Akorn buys rival generic drugmaker for $640 million

27-08-2013

USA-based generics drugmaker Akorn (Nasdaq: AKRX) has bought rival generic drugmaker Hi-Tech Pharmacal…

AkornGenericsHi-Tech PharmacalMergers & AcquisitionsNorth America

Mylan's deal to acquire Strides Arcolab's unit looks set to proceed

22-08-2013

US generics and specialty drugmaker Mylan (NYSE: MYL) $1.6-billion foreign direct investment proposal…

Agila SpecialitesAsia-PacificGenericsMergers & AcquisitionsMylan LaboratoriesRegulationStrides Arcolab

Stada Arz buys UK OTC manufacturer

21-08-2013

German generic and branded drugmaker Stada Arzneimittel (SAZ: GR) signed and concluded a contract for…

FinancialGenericsMergers & AcquisitionsPharmaceuticalSTADA ArzneimittelThornton & Ross

Fresenius Kabi sets up JV for IV generics in Indonesia

20-08-2013

Germany-based Fresenius Kabi, part of the Fresenius Group (FRE: Xetra) has formed a joint venture with…

Asia-PacificFreseniusFresenius KabiGenericsMarkets & MarketingMergers & AcquisitionsSoho Global Health

Pharmstandard agrees key terms for acquiring Singapore drugmaker

14-08-2013

Russia's largest pharma company Pharmstandard (PHST RU) - with a market capitalization of around $2 billion…

Bever PharmaceuticalGenericsMergers & AcquisitionsPharmstandard

Breckenridge to acquire certain Cypress assets

12-08-2013

Privately-held US generic drugmaker Breckenridge Pharmaceutical has entered into an agreement to acquire…

Breckenridge PharmaceuticalsCypress PharmaceuticalsGenericsMergers & AcquisitionsPernix Therapeutics

Luxembourg Haden increases its stake in Bosnia's largest drugmaker

03-08-2013

Investment firm Luxembourg Haden, which is reportedly affiliated with the well-known Russian drug distributor…

BosnalijekGenericsImperia PharmaLuxembourg HadenMergers & Acquisitions

Pfizer to separate business into three units: will this lead to spin-outs?

29-07-2013

Moving in a direction already advocated by several analysts, US pharma behemoth Pfizer (NYSE: PFE) today…

GenericsManagementMergers & AcquisitionsPfizerPharmaceutical

Elan board agrees $8.6 billion takeover bid

29-07-2013

US health care company Perrigo (NYSE: PRGO) revealed this morning that Ireland-based drugmaker Elan Corp…

ElanGenericsMergers & AcquisitionsPerrigoPharmaceuticalTysabri

Teva and Lonza to discontinue their biosimilars collaboration

25-07-2013

Israel-based Teva Pharmaceuticals Industries (NYSE: TEVA), the world's leading generics drugmaker, and…

GenericsLonzaMergers & AcquisitionsRest of the WorldTeva Pharmaceutical Industries

Recordati acquires Tunisian drugmaker

25-07-2013

Italian drugmaker Recordati (RC: MI) has singed announces the signature of the agreements covering the…

GenericsMergers & AcquisitionsOpalia PharmaPharmaceuticalRecordati

Generics briefs: Actavis/Warner Chilcott M&A delay; Canasa patent challenge

11-07-2013

US generics major Actavis (NYSE: ACT) and Ireland-based Warner Chilcott (Nasdaq: WCRX) have each received…

ActavisAptalis PharmaCanasaGenericsLegalMergers & AcquisitionsMylan LaboratoriesNorth AmericaPatentsWarner Chilcott

Pharmstandard confirms OTC spin-off and in talks to buy Bever Pharma

10-07-2013

Russia's largest drugmaker Pharmstandard OJSC (PHST RU) has confirmed that it has initiated steps for…

Bever PharmaceuticalGenericsMergers & AcquisitionsPharmaceuticalPharmstandard

Mylan stumbles in $1.6 billion bid to take over injectables specialist Agila Specialties in India

09-07-2013

US generics and specialty drugs company Mylan (NYSE: MYL) faces a setback in its plan to acquire Indian…

Agila SpecialitesGenericsMergers & AcquisitionsMylan LaboratoriesStrides Arcolab

South Africa's Adcock Ingram confirms takeover bid from CFR Pharma

04-07-2013

In what was described as a "cautionary" statement, South Africa's largest drugmaker Adcock Ingram (AIP:…

Adcock IngramCFR PharmaceuticalsGenericsMergers & AcquisitionsPharmaceutical

Mayne Pharma makes second US acquisition, this time generic drugmaker Libertas

03-07-2013

In a second move into the US market in less than a year, Australia's Mayne Pharma (ASX: MYX) says it…

GenericsLibertas PharmaMayne PharmaMergers & Acquisitions

Perrigo acquires ophthalmic portfolio from Fera Pharma for initial $93 million

18-06-2013

Generic drugmaker Perrigo (NYSE: PRGO) says it has signed a definitive agreement to acquire and has completed…

Fera PharmaceuticalsGenericsMergers & AcquisitionsOphthalmicsPerrigo

Fujifilm and Dr Reddy's abandon plans for generics JV in Japan

04-06-2013

Japan's Fujifilm Corp and Indian drugmaker Dr Reddy's Laboratories (NYSE: RDY) have decided to terminate…

Dr Reddy's LaboratoriesFujifilmGenericsMergers & AcquisitionsProduction

Novo A/S acquires Norway's Xellia Pharmaceuticals in $700 million deal

21-05-2013

Denmark-based Novo A/S, the holding company of the Novo Group and the major shareholder in Novo Nordisk…

Antibiotics and Infectious diseasesGenericsMergers & AcquisitionsNovo A/SNovo NordiskPharmaceuticalXellia Pharmaceuticals

Actavis confirms plan to acquire Warner Chilcott, in $8.5 billion deal

20-05-2013

US generics major Actavis (NYSE: ACT) revealed today (May 20) that it has entered into a definitive agreement…

ActavisGenericsMergers & AcquisitionsPharmaceuticalWarner ChilcottWomen's Health

Actavis and Warner Chilcott leap on merger talks; possible bid for Adcock Ingram

13-05-2013

US generics major Actavis NYSE: ACT) confirmed on Friday (May 10) that it has entered into early stage…

ActavisAdcock IngramFinancialGenericsMergers & AcquisitionsPharmaceuticalWarner Chilcott

Sagent Pharma to buy remaining 50% stake in Chinese JV for $25 million

06-05-2013

US specialty pharmaceutical company Sagent Pharmaceuticals (Nasdaq: SGNT) has entered into an agreement…

Asia-PacificGenericsKanghong Sagent (Chengdu) PharmaceuticalMergers & AcquisitionsPharmaceuticalProductionSagent Pharmaceuticals

Arseus/Fagron acquire US pharma compounder Freedom Pharma

01-05-2013

USA-based Freedom Pharmaceuticals says that it has been acquired by Arseus, the holding company for Fagron,…

ArseusFagronFreedom PharmaceuticalsGenericsMergers & AcquisitionsPharmaceutical

76 to 100 of 175 results

Back to top